Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceCombined Modality TherapyMice, Inbred C57BLRadiation ChimeraTreatment OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteTime FactorsImmunosuppressive AgentsRemission InductionGraft RejectionHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidImmunosuppressionStem Cell TransplantationLymphocyte DepletionLymphoma, Non-HodgkinRetrospective StudiesAcute DiseaseLeukocyte TransfusionHeart TransplantationSurvival AnalysisSevere Combined ImmunodeficiencyT-LymphocytesChimeraColony-Forming Units AssayHLA AntigensMyelodysplastic SyndromesLung TransplantationActuarial AnalysisCyclosporineHematologic DiseasesBone DensityLymphocyte TransfusionFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyOrgan TransplantationCarmustineSurvival RateCell DifferentiationPancytopeniaGraft vs Tumor EffectGraft vs Leukemia EffectLeukocyte CountCytarabineCytomegalovirus InfectionsSpleenBone ResorptionGranulocyte Colony-Stimulating FactorDisease-Free SurvivalMelphalanMice, Inbred BALB CEtoposideLymphomaFlow CytometryMultiple MyelomaCells, CulturedPrognosisFatal OutcomeHodgkin DiseaseMice, KnockoutAntigens, CD34InfectionCell TransplantationCord Blood Stem Cell TransplantationGranulocytes